Teladoc Health (NYSE:TDOC) Sets New 1-Year Low – What’s Next?

Teladoc Health, Inc. (NYSE:TDOC) hit a new 52-week low on Monday . The company traded as low as $5.39 and last traded at $5.4090, with a volume of 6613892 shares. The stock had previously closed at $5.70.

Wall Street Analysts Forecast Growth

TDOC has been the subject of a number of research reports. Bank of America lowered their price target on shares of Teladoc Health from $9.00 to $8.00 and set a “neutral” rating for the company in a report on Tuesday, November 25th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Teladoc Health in a research note on Monday, December 29th. Evercore ISI cut their target price on shares of Teladoc Health from $9.00 to $8.00 and set an “in-line” rating on the stock in a research report on Thursday, October 30th. Zacks Research cut shares of Teladoc Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 10th. Finally, Citigroup cut their price objective on shares of Teladoc Health from $10.00 to $9.00 and set a “neutral” rating on the stock in a report on Friday, January 9th. Three analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Hold” and an average target price of $9.12.

Teladoc Health Stock Down 1.9%

The firm has a market cap of $890.01 million, a P/E ratio of -3.93 and a beta of 2.12. The firm’s 50 day moving average is $6.96 and its two-hundred day moving average is $7.55. The company has a current ratio of 2.70, a quick ratio of 2.60 and a debt-to-equity ratio of 0.71.

Insider Activity

In other Teladoc Health news, insider Fernando M. Rodrigues sold 4,209 shares of Teladoc Health stock in a transaction dated Wednesday, December 3rd. The stock was sold at an average price of $7.48, for a total transaction of $31,483.32. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, insider Adam C. Vandervoort sold 5,720 shares of the firm’s stock in a transaction dated Tuesday, December 2nd. The stock was sold at an average price of $7.49, for a total value of $42,842.80. Following the sale, the insider directly owned 80,732 shares in the company, valued at approximately $604,682.68. This represents a 6.62% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 33,288 shares of company stock worth $251,684 in the last 90 days. Corporate insiders own 0.58% of the company’s stock.

Hedge Funds Weigh In On Teladoc Health

A number of large investors have recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of Teladoc Health by 2.8% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 193,714 shares of the health services provider’s stock valued at $1,542,000 after purchasing an additional 5,235 shares during the last quarter. NewEdge Advisors LLC grew its position in Teladoc Health by 1,278.7% in the first quarter. NewEdge Advisors LLC now owns 11,305 shares of the health services provider’s stock valued at $90,000 after purchasing an additional 10,485 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its stake in Teladoc Health by 5.7% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 447,992 shares of the health services provider’s stock valued at $3,566,000 after buying an additional 24,124 shares during the last quarter. Acadian Asset Management LLC bought a new stake in Teladoc Health during the 1st quarter worth about $615,000. Finally, Ameritas Advisory Services LLC acquired a new position in shares of Teladoc Health during the 2nd quarter worth about $78,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.